These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1138420)

  • 1. Sodium acetate buffer: a diluent of choice in the clot lysis time technique.
    Chohan IS; Vermylen J; Singh I; Balakrishnan K; Verstraete M
    Thromb Diath Haemorrh; 1975 Apr; 33(2):226-9. PubMed ID: 1138420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinolytic activity at high altitude and sodium acetate buffer.
    Chohan IS; Singh I; Balakrihsnan K
    Thromb Diath Haemorrh; 1974 Sep; 32(1):65-70. PubMed ID: 4454046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of diluents on blood clot lysis.
    Gallimore MJ
    J Clin Pathol; 1967 May; 20(3):234-8. PubMed ID: 5628854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new euglobulin clot lysis assay for global fibrinolysis.
    Smith AA; Jacobson LJ; Miller BI; Hathaway WE; Manco-Johnson MJ
    Thromb Res; 2003; 112(5-6):329-37. PubMed ID: 15041279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation.
    Mosnier LO; von dem Borne PA; Meijers JC; Bouma BN
    Thromb Haemost; 1998 Nov; 80(5):829-35. PubMed ID: 9843179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
    von dem Borne PA; Cox LM; Bouma BN
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heritability of clot formation, morphology, and lysis: the EuroCLOT study.
    Carter AM; Cymbalista CM; Spector TD; Grant PJ;
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2783-9. PubMed ID: 17932316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro study of homocysteine and aspirin effects on fibrinolysis: measuring fibrinolysis parameters.
    Zavar-Reza J; Pouya FD; Jalali BA; Gholami F; Pouya ND
    Blood Coagul Fibrinolysis; 2014 Jan; 25(1):1-5. PubMed ID: 24374649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration.
    Mosnier LO; Lisman T; van den Berg HM; Nieuwenhuis HK; Meijers JC; Bouma BN
    Thromb Haemost; 2001 Oct; 86(4):1035-9. PubMed ID: 11686321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothermia and acidosis synergistically impair coagulation in human whole blood.
    Dirkmann D; Hanke AA; Görlinger K; Peters J
    Anesth Analg; 2008 Jun; 106(6):1627-32. PubMed ID: 18499589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of coagulation and fibrinolysis parameters for diagnostics of disseminated intravascular blood coagulation (DIC).
    Lezhen T; Kramarev S; Kolesnik L; Kudinov S
    Mater Med Pol; 1992; 24(2):79-81. PubMed ID: 1307773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-type plasminogen activator (t-PA) and dilute blood clot lysis time in nephrotic patients.
    Cucuianu MP; Rus HG; Roman S; Mărcuşu C; Spînu C; Manasia M; Niculescu F
    Thromb Haemost; 1989 Apr; 61(2):270-4. PubMed ID: 2501897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multiparameter test of clot formation and fibrinolysis for in-vitro drug screening.
    Kostka B; Para J; Sikora J
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):611-8. PubMed ID: 17890947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significant enhancement of fibrinolysis by calcium ion in a cell free system: the shortening of euglobulin clot lysis time by calcium ion.
    Kojima Y; Urano T; Kojima K; Serizawa K; Takada Y; Takada A
    Thromb Haemost; 1994 Jul; 72(1):113-8. PubMed ID: 7974358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A reconstituted dilute blood clot lysis assay for the medium throughput screening of thrombolytic compounds.
    Gadbut AP; Schullek JR; Hanel AM; MacAllan DR
    Anal Biochem; 1999 May; 270(1):24-32. PubMed ID: 10328761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
    Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variables influencing the clot lysis assay of streptokinase.
    Westlund LE; Andersson LO
    Thromb Res; 1991 Dec; 64(6):713-21. PubMed ID: 1798960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fibrinolysis: kinetics of the lysis of a fibrin clot].
    Daver J; Edmond E; Panak E; Ricoeur M
    Rev Eur Etud Clin Biol; 1970 Mar; 15(3):333-42. PubMed ID: 4246032
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dilute blood clot lysis test].
    Bizzi B; Leone G; Accorrà F
    Riv Crit Clin Med; 1968; 68():Suppl 6:1146+. PubMed ID: 5748412
    [No Abstract]   [Full Text] [Related]  

  • 20. Alpha 2-antiplasmin, plasminogen activator inhibitor (PAI) and dilute blood clot lysis time in selected disease states.
    Cucuianu M; Knauer O; Roman S
    Thromb Haemost; 1991 Nov; 66(5):586-91. PubMed ID: 1725069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.